{"title":"The Impact of Parental Collaborative Care on Alleviating Cardiovascular Risk Factors in Adolescents","authors":"Fujuan Chen, Yanfen Liao, Bingshan Chen","doi":"10.11648/j.ccr.20230703.13","DOIUrl":"https://doi.org/10.11648/j.ccr.20230703.13","url":null,"abstract":"","PeriodicalId":92185,"journal":{"name":"Cardiology research and cardiovascular medicine","volume":"164 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86443843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Distribution of Cardiovascular Risk Among Diabetic Patients in Kumasi","authors":"Shiako Joshua Tei, Dassah Ebenezer, Adu-Gyamfi Adwoa Agyemang, Brenyah Joseph Kwasi","doi":"10.11648/j.ccr.20230703.11","DOIUrl":"https://doi.org/10.11648/j.ccr.20230703.11","url":null,"abstract":"","PeriodicalId":92185,"journal":{"name":"Cardiology research and cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75430441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Scaffold and Cell-Based Tissue Engineering Approaches as Alternative Therapy for Blood Vessel Disease","authors":"S. Sassi, Tatsuya Watanabe, T. Shinoka","doi":"10.29011/2575-7083.100097","DOIUrl":"https://doi.org/10.29011/2575-7083.100097","url":null,"abstract":"Cardiovascular diseases remain the leading cause of mortality worldwide. Although new therapies are actively being developed and used for cardiovascular pathologies, these attempts have not significantly decreased mortality rates. Regenerative medicine has made enormous progress and set promising approaches over the past half-century. However, since autologous (donor-derived) vascular grafts are lacking, an alternative prosthesis must be constructed for cardiovascular disease patients. In vascular tissue manufacturing and regenerative medicine, scientists seek to improve this significant clinical challenge using bio-fabrication techniques combining additive manufacturing, biomaterials science","PeriodicalId":92185,"journal":{"name":"Cardiology research and cardiovascular medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42811478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bruno Morabito, A. Rabini, Ludovica Leo, F. Cammertoni, Francesco Maria Fazzone, Matteo Armenti, D. Silvestri, N. Aspromonte, M. Massetti, M. Bruno
{"title":"PRE-STAR: Multidimensional Pre-Habilitation in Patients with Aortic Stenosis Undergoing Surgical Valve Replacement","authors":"Bruno Morabito, A. Rabini, Ludovica Leo, F. Cammertoni, Francesco Maria Fazzone, Matteo Armenti, D. Silvestri, N. Aspromonte, M. Massetti, M. Bruno","doi":"10.29011/2575-7083.100095","DOIUrl":"https://doi.org/10.29011/2575-7083.100095","url":null,"abstract":"in Patients","PeriodicalId":92185,"journal":{"name":"Cardiology research and cardiovascular medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42978941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shijie Zhou, Lidong Zhai, Zhai L. Cardiolog, Res Cardiovasc
{"title":"Inflammatory Causes and Immunotherapy Potential in Cardiovascular Diseases Treatment","authors":"Shijie Zhou, Lidong Zhai, Zhai L. Cardiolog, Res Cardiovasc","doi":"10.29011/2575-7083.100096","DOIUrl":"https://doi.org/10.29011/2575-7083.100096","url":null,"abstract":"Inflammatory profile in the cardiovascular diseases has been acknowledged widely; yet the potential of immunotherapy in the treatment of cardiovascular diseases (CVD) is not fully met. The primary and secondary inflammatory risk factors of CVD; as well as drivers of atherosclerosis from the immune system are elaborated in this review. The approaches to treat CVD in respect of immunotherapy focus on targeting cytokine response pathways; novel engineering cytokines and superkines; and targeting specialized pro-resolving mediators (SPMs) in atherosclerosis. Immunotherapy in the treatment of heart failure has gained great advancement in targeting heart fibrosis to stop and even reverse cardiac remodeling. With a deeper understanding of the roles T cells and macrophages in the development of fibrosis in heart failure; harnessing them became possible to treat heart failure. T-cell therapy with chimeric antigen receptor (CAR T-cell); as well as CRISPR gene editing therapy make personalized diagnosis and treatment possible and bring a lot of hope to concur this debilitating disease. This review attempts to summarize new understandings of inflammatory mechanisms underlying CVD and major advancements as well as challenges in CVD immunotherapy with a hope to offer a perspective on strategies to advance future therapies.","PeriodicalId":92185,"journal":{"name":"Cardiology research and cardiovascular medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47803013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effect of Local High-Frequency Vibration Therapy (LMV) Undergoing Minimally Invasive Cardiac Surgery A Randomized Controlled Trial (RCT)","authors":"","doi":"10.29011/2575-7083.100094","DOIUrl":"https://doi.org/10.29011/2575-7083.100094","url":null,"abstract":"","PeriodicalId":92185,"journal":{"name":"Cardiology research and cardiovascular medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43702146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. H. Alghamdi, A. Alaryni, M. Alshammri, S. Hadi, Hussain Gadelkarim, Prof. Hussain Gadelkarim, Ahmed
{"title":"Association of Chronic Kidney Disease and Coronary Heart Disease in A Series of Saudi Patients","authors":"A. H. Alghamdi, A. Alaryni, M. Alshammri, S. Hadi, Hussain Gadelkarim, Prof. Hussain Gadelkarim, Ahmed","doi":"10.29011/2575-7083.100093","DOIUrl":"https://doi.org/10.29011/2575-7083.100093","url":null,"abstract":"Objectives: this study aimed to assess the association between CKD and coronary heart disease (CHD) in a series of Saudi patients. Methods: This study investigated 2700 Saudi volunteers during a cross-sectional survey conducted in Hai’l region. Participants were included based randomly regardless of age or gender. CKD stage was determined according to GFR estimation using creatinine level, age, and sex. Results: The risk of CHD associated with CKD, the relative risk (RR), and the 95% confidence interval was RR (95%CI) = 8.5045(4.5035 to 16.0602), P < 0.0001. The risk of CHD among patients above 41 years was statistically significant, with the RR (95%CI) = 5.6978 (2.3849 to 13.6126), P = 0.0001. The risk of CHD associated with FHRD was the RR (95%CI) = 5.2567 (2.5146 to 10.9891), P = 0.0001. Conclusion: There is a statistically significant association between CKD and CHD in a population with shared risk factors such as hypertension, diabetes, and obesity. A statistically significant positive association between CKD & CHD and Saudi rural inhabitants, family history of renal disease, and ex-smoking.","PeriodicalId":92185,"journal":{"name":"Cardiology research and cardiovascular medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43424729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}